SCHEMBL24752530

SCHEMBL24752530

c1ccc(-c2cccc(-c3cc(-c4ccc(-c5ccc(-c6ccc(-n7c8ccccc8c8ccccc87)cc6)cc5)c5ccccc45)nc(-c4ccccc4)n3)c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 4/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ ATM Q13315 1/20 0.41
▸ HPGD P15428 5/20 0.40
▸ MEN1 O00255 4/20 0.40
▸ KMT2A Q03164 4/20 0.40
▸ ALDH1A1 P00352 4/20 0.40
▸ MAPT P10636 4/20 0.40
▸ LMNA P02545 2/20 0.40
▸ GLA P06280 1/20 0.40
▸ NTSR1 P30989 1/20 0.38
▸ MAPK1 P28482 1/20 0.36
▸ TDP1 Q9NUW8 1/20 0.36
▸ HDAC4 P56524 1/20 0.36
▸ AKR1C4 P17516 1/20 0.35
▸ AKR1C3 P42330 1/20 0.35
▸ AKR1C2 P52895 1/20 0.35
▸ AKR1C1 Q04828 1/20 0.35
▸ MAOB P27338 2/20 0.34
▸ ACACA Q13085 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24752501 1.00 KDM4E (0.41) KDM4EL3MBTL1ATMHPGDMEN1
SCHEMBL26432034 1.00 KDM4E (0.41) KDM4EL3MBTL1ATMHPGDMEN1
SCHEMBL24787771 0.94 HPGD (0.36) KDM4EL3MBTL1ATMHPGDMEN1
SCHEMBL24752513 0.94 KDM4E (0.41) KDM4EL3MBTL1ATMHPGDMEN1
SCHEMBL24752072 0.94 KDM4E (0.41) KDM4EL3MBTL1ATMHPGDMEN1
SCHEMBL24752528 0.94 KDM4E (0.40) KDM4EL3MBTL1ATMHPGDMEN1
SCHEMBL26432032 0.94 KDM4E (0.41) KDM4EL3MBTL1ATMHPGDMEN1
SCHEMBL24788042 0.94 KMT2A (0.44) KDM4EL3MBTL1ATMHPGDMEN1
SCHEMBL24752456 0.94 KMT2A (0.44) KDM4EL3MBTL1ATMHPGDMEN1
SCHEMBL24752457 0.94 KMT2A (0.44) KDM4EL3MBTL1ATMHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-04-27 — — US disclosed
EP-4101851-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE Idemitsu Kosan Co., Ltd (JP) 2022-12-14 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230127629-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, EPCAM, TMEM109 KDM4E 3098/4885L3MBTL1 1434/4885ATM 2552/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback